Skip to main content

Table 1 Overview of m1A detection methods

From: Research progress of N1-methyladenosine RNA modification in cancer

Detection method

Feature

Advantage

Drawback

Function

Article source

2D-TLC

differential retention values(Rf values)

ease and cheap

hydrolysis and 32P labeling steps may have bias

[17]

HPLC

differential retention, enzymatic RNA digestion

faster no radiolabeling

loss of sequence information

analysis of modifications with high abundance

[17, 18]

LC-MS

HPLC, mass Spectrometry

high accuracy and sensitivity

loss of sequence information

detect and quantify the m1A level in mRNA

[15, 17, 19]

Primer-extension

block base pairing compared cDNA bands

Precise modification position

RNA targets of high abundance and existing sequence knowledge

validate the new detection technique

[17]

ARM-Seq

ALKB treatment

sensitive and accuracy

Assay escape modification, Analysis of RNA modification and processing sequences

[20]

m1A-ID-seq

RNA Immu-opreipitaion with ALKB assisted

no cross-reactivity

m1A was difficult to obtain, rely on specific m1A antibody

the first trans-criptomewide characterization of m1A

[21]

MeRIP-seq-or-m1A-seq

Dimroth rearrangement, immune-oprecipitation

low mutation rate, lower mismatch rate

rely on specific m1A antibody

[22]

m1A-MAP-seq

Immun-oprecipitation, AlkB treatment, TGIRT-mediated RT, ligation-based strand-specific library preparation protocol

Excellent readthrough efficiency and relatively high mutation frequency

TGIRT Under-estimated the m1A level, the sequence context of RNA affect the mutation rate

identify m1A modification at mRNA cap, and GUUCRA tRNA-like sequencemotif

[6]

m1A-IP-seq

ALKB treatment, immun-oprecipitation, Differential abundance analysis, RT-1306-mediated RT mutation

capture robustly mutation signature, good reproducibility, wide transcriptome coverage, high alignment rate to the genome

data re-producibility worse, false negatives, disable the detection of potential sites at or near the 5′-cap

discovered hundreds of new m1A sites in human mRNA

[6]

m1A-quant-seq

ALKB treatment spike-in RNA RT1306-mediated RT mutation

Mutation signatures and sensitivity to AlkB treatment are robustly observed

false negatives result, disable the detection of potential sites at or near the 5′-cap

estimate m1A stoichiometries at individual sites in the transcriptome

[6]

m1A-seq-TGIRT

Immun-oprecipitation, Dimroth rearrangement, TGIRT-mediated RT

identifying individual modified bases, higher misincorporation rates, not require adapter ligation

low truncation rates, low RT activity

redefinition of m1A genome-wide distribution

[6, 23, 24]

m1A-seq-SS

immunoprecipitation, Dimroth rearrangement, SS-mediated RT

identifying individual modified bases, premature truncations

[23]